Received Oct 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (in JAN-2023). On an unknown date, the patient received Shingrix. On an unknown date, 2 weeks after receiving Shingrix, the patient experienced shingles (Verbatim: Shingles). The outcome of the shingles was not reported. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 06-OCT-2025 This case was reported by a patient via interactive digital media. The patient got shingles in January 2023 and had three nerve blocks and the third one had to be resuscitated and didn't have a fourth and the patient still have severe pain. The patient went to a new doctor and got the Shingrix vaccine and two weeks later a new case of shingles and said get it as soon as you can. Unless you have had it, you cannot even try to fathom how painful it is.
Medical History/Concurrent Conditions: Shingles (in JAN-2023)